Kevin Mcnamara Sells 2,000 Shares of Chemed (NYSE:CHE) Stock

Chemed Corporation (NYSE:CHE) CEO Kevin Mcnamara sold 2,000 shares of the firm’s stock in a transaction dated Friday, May 1st. The shares were sold at an average price of $421.13, for a total transaction of $842,260.00. Following the completion of the sale, the chief executive officer owned 90,219 shares in the company, valued at $37,993,927.47. This represents a 2.17% decrease in their ownership of the stock. The transaction was disclosed in a filing with the SEC, which is available at this hyperlink.

Chemed Stock Up 0.5%

NYSE:CHE opened at $427.85 on Wednesday. Chemed Corporation has a fifty-two week low of $365.20 and a fifty-two week high of $583.96. The stock has a market capitalization of $5.68 billion, a P/E ratio of 23.32, a P/E/G ratio of 1.60 and a beta of 0.54. The company has a debt-to-equity ratio of 0.11, a quick ratio of 0.83 and a current ratio of 0.85. The company’s 50-day simple moving average is $398.34 and its 200-day simple moving average is $425.88.

Chemed (NYSE:CHE) last released its quarterly earnings results on Thursday, April 23rd. The company reported $5.65 earnings per share for the quarter, beating analysts’ consensus estimates of $5.30 by $0.35. Chemed had a net margin of 10.23% and a return on equity of 27.18%. The business had revenue of $657.51 million for the quarter, compared to analysts’ expectations of $659.22 million. During the same period last year, the business earned $5.63 EPS. The company’s revenue was up 1.6% compared to the same quarter last year. Chemed has set its FY 2026 guidance at 24.000-24.75 EPS. On average, equities analysts anticipate that Chemed Corporation will post 22.3 earnings per share for the current fiscal year.

Chemed Dividend Announcement

The business also recently disclosed a quarterly dividend, which was paid on Friday, March 13th. Investors of record on Monday, February 23rd were given a $0.60 dividend. This represents a $2.40 annualized dividend and a dividend yield of 0.6%. The ex-dividend date of this dividend was Monday, February 23rd. Chemed’s dividend payout ratio (DPR) is presently 13.08%.

Analyst Ratings Changes

CHE has been the subject of several research analyst reports. Royal Bank Of Canada increased their price objective on shares of Chemed from $422.00 to $436.00 and gave the company a “sector perform” rating in a research report on Monday, April 27th. Weiss Ratings raised shares of Chemed from a “sell (d+)” rating to a “hold (c-)” rating in a research report on Wednesday, April 29th. Oppenheimer decreased their price objective on shares of Chemed from $580.00 to $500.00 and set an “outperform” rating for the company in a research report on Friday, February 27th. Jefferies Financial Group lowered shares of Chemed from a “buy” rating to a “hold” rating in a research report on Thursday, January 22nd. Finally, Wall Street Zen raised shares of Chemed from a “hold” rating to a “buy” rating in a research report on Saturday. Two research analysts have rated the stock with a Buy rating and four have assigned a Hold rating to the company. According to MarketBeat, Chemed presently has an average rating of “Hold” and a consensus price target of $501.50.

Hedge Funds Weigh In On Chemed

Hedge funds and other institutional investors have recently bought and sold shares of the business. Monetary Solutions Ltd acquired a new position in Chemed in the 4th quarter worth approximately $25,000. Los Angeles Capital Management LLC purchased a new position in shares of Chemed during the 4th quarter valued at about $26,000. Smartleaf Asset Management LLC raised its stake in shares of Chemed by 71.4% during the 3rd quarter. Smartleaf Asset Management LLC now owns 60 shares of the company’s stock valued at $27,000 after buying an additional 25 shares during the last quarter. BOK Financial Private Wealth Inc. purchased a new position in shares of Chemed during the 4th quarter valued at about $27,000. Finally, First Horizon Corp purchased a new position in shares of Chemed during the 3rd quarter valued at about $31,000. Institutional investors and hedge funds own 95.85% of the company’s stock.

Chemed Company Profile

Chemed Corporation is a diversified provider of essential home services and healthcare solutions in the United States. Headquartered in Cincinnati, Ohio, the company operates through two principal business segments—Roto-Rooter and Vitas Healthcare. Since its founding in 1974, Chemed has built a reputation for reliability and expertise, serving both residential and commercial customers across a broad range of markets.

The Roto-Rooter segment offers a comprehensive suite of plumbing, drain cleaning and water restoration services.